Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.2103
S.2103: Affordable Insulin Approvals Now Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced July 11, 2019
- Latest Major Action July 11, 2019
Bill Sponsor
Bill Cosponsors
16 (7 Democrats, 9 Republicans)
Bill Version
- Introduced in Senate - July 11, 2019
Bill Summary
Affordable Insulin Approvals Now ActThis bill requires the continued review and approval, as appropriate, of certain pending applications for generic insulin beyond the March 23, 2020, cutoff date previously established by the Food and Drug Administration. Beginning March 23, 2020, these approved generic insulin drugs also are deemed licensed biological products.
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| July 11, 2019 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| July 11, 2019 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4809)
|
| July 11, 2019 |
Introduced in the Senate by Richard J. Durbin (D-Ill.) |